(Q43566087)

24 November 2017

Stromal adipocyte PPARγ protects against breast tumorigenesis (English)

1 reference

24 November 2017

1 reference

Graham Skelhorne-Gross

1

1 reference

24 November 2017

Alexis L Reid

2

1 reference

24 November 2017

Anthony J Apostoli

3

1 reference

24 November 2017

Michael A Di Lena

4

1 reference

24 November 2017

Rachel E Rubino

5

1 reference

24 November 2017

Nichole T Peterson

6

1 reference

24 November 2017

Mark Schneider

7

1 reference

24 November 2017

Sandip K SenGupta

8

1 reference

24 November 2017

Frank J Gonzalez

9

1 reference

24 November 2017

Christopher J B Nicol

10

1 reference

24 November 2017

language of work or name

English

0 references

publication date

11 May 2012

1 reference

24 November 2017

1 reference

24 November 2017

33

1 reference

24 November 2017

7

1 reference

24 November 2017

1412-1420

1 reference

BRCA1 and BRCA2 in breast cancer

24 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Peroxisome proliferator-activated receptors: from genes to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Terminal differentiation of human breast cancer through PPAR gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Effect of obesity on breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Biotransformation and bioactivation of 7, 12-dimethylbenz[a]anthracene (7, 12-DMBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Multistage carcinogenesis in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

The impairment of reproduction in db/db mice is not mediated by intraovarian defective leptin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Transcriptional autoregulation by BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Alpha-eleostearic acid suppresses proliferation of MCF-7 breast cancer cells via activation of PPARgamma and inhibition of ERK 1 / 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Biological action of leptin as an angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

Obesity and breast cancer: status of leptin and adiponectin in pathological processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS173

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS173

1 reference

24 November 2017

1 reference